Tonguc T, Savchenko O, Ramig O, Stader J, Kiessling F, Kuppers J
Radiol Med. 2025; .
PMID: 40063166
DOI: 10.1007/s11547-025-01972-6.
Jokinen V, Taira A, Kolterud A, Ahlgren I, Palin K, Katainen R
BJC Rep. 2025; 3(1):9.
PMID: 40016412
PMC: 11868550.
DOI: 10.1038/s44276-025-00127-4.
Yang Y, Pan M, Zhu W, Luo X, Liang X
BMC Womens Health. 2025; 25(1):68.
PMID: 39966823
PMC: 11834190.
DOI: 10.1186/s12905-025-03596-4.
Wang X, Li J, Liu Y, Zheng Y, Wang X, Liu G
Gland Surg. 2025; 14(1):60-73.
PMID: 39958902
PMC: 11826254.
DOI: 10.21037/gs-24-386.
Akerele A, Piekos J, Kim J, Khankari N, Hellwege J, Edwards T
Pac Symp Biocomput. 2024; 30:281-295.
PMID: 39670377
PMC: 11649017.
Mifepristone's Efficacy for Symptomatic Relief and Size Reduction in Uterine Fibroids: A 2023 Prospective Observational Study at Rabia Balkhi Hospital, Afghanistan.
Yousofzai B, Alami M, Sheela S, Subhan M, Bibi R, Ali A
Cureus. 2024; 16(11):e73432.
PMID: 39664156
PMC: 11633070.
DOI: 10.7759/cureus.73432.
Large subserous uterine leiomyoma presenting as intraabdominal tumor: A case report.
Ashindoitiang J, Canice Nwagbara V, Edet E, Ugbem T, Ukam J, Asuquo M
Rare Tumors. 2024; 16:20363613241285089.
PMID: 39290295
PMC: 11406654.
DOI: 10.1177/20363613241285089.
Giant "Hydra Headed" Uterine Fibroid in a Nullipara: A Case Report.
Igbodike E, Iwuala I, Mbonu C, Okechukwu U, Funtua A, Eleje G
Clin Med Insights Case Rep. 2024; 17:11795476241274689.
PMID: 39286445
PMC: 11403671.
DOI: 10.1177/11795476241274689.
The Differential Diagnosis of Abdominal Mass: A Case of Uterine Leiomyoma.
Ghildiyal S, Somalwar S, Bhalerao A, Jain S
Cureus. 2024; 16(7):e65126.
PMID: 39170990
PMC: 11338543.
DOI: 10.7759/cureus.65126.
The effect of ulipristal acetate on tumor necrosis factor α, insulin-like growth factor 1, and plasminogen activator inhibitor-1 serum levels in patients with symptomatic uterine fibroids.
Ciebiera M, Jakiel G, Nowicka G, Lagana A, Ghezzi F, Lozinski T
Arch Med Sci. 2024; 20(3):751-761.
PMID: 39050181
PMC: 11264157.
DOI: 10.5114/aoms.2020.94296.
Multiparametric quantitative magnetic resonance imaging of uterine fibroids for prediction of growth rate-a pilot study.
Medved M, Harmath C, Siblini H, Giurcanu M, Kulkarni K, Hellman K
Quant Imaging Med Surg. 2024; 14(7):4362-4375.
PMID: 39022288
PMC: 11250352.
DOI: 10.21037/qims-23-1663.
Data-driven analyses to quantify information seeking behaviour for women with uterine fibroids.
Derico S, Hicklin K, Davis L, Brooks K
Health Syst (Basingstoke). 2024; 13(2):73-96.
PMID: 38800604
PMC: 11123465.
DOI: 10.1080/20476965.2022.2150570.
The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
Kitade M, Kumakiri J, Kobori H, Murakami K
Trials. 2024; 25(1):343.
PMID: 38790029
PMC: 11127340.
DOI: 10.1186/s13063-024-08170-1.
Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women.
Hoffman S, Smith J, Funk M, Hudgens M, Poole C, Nicholson W
PLoS One. 2024; 19(5):e0303823.
PMID: 38781223
PMC: 11115284.
DOI: 10.1371/journal.pone.0303823.
Cesarean Myomectomy: Reflections on Clinical and Surgical Controversies between a New Trans-Decidual Technique vs. Traditional Method.
Sparic R, Andric L, Guler O, Malvasi A, Babovic I, Hatirnaz S
Medicina (Kaunas). 2024; 60(4).
PMID: 38674255
PMC: 11052397.
DOI: 10.3390/medicina60040609.
Gene variants polymorphisms and uterine leiomyoma: an updated review.
Upadhyay S, Dubey P
Front Genet. 2024; 15:1330807.
PMID: 38572418
PMC: 10987786.
DOI: 10.3389/fgene.2024.1330807.
Enhancing Uterine Fibroid Care: Clinician Perspectives on Diagnosis, Disparities, and Strategies for Improving Health Care.
Laily A, Nair I, Shank S, Wettschurack C, Khamis G, Dykstra C
Womens Health Rep (New Rochelle). 2024; 5(1):293-304.
PMID: 38558944
PMC: 10979696.
DOI: 10.1089/whr.2023.0113.
Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to 2019: A worldwide database study.
Dai Y, Chen H, Yu J, Cai J, Lu B, Dai M
Chin Med J (Engl). 2024; 137(21):2583-2589.
PMID: 38407293
PMC: 11556989.
DOI: 10.1097/CM9.0000000000002971.
Uterine Fibroid Prevalence in a Predominantly Black, Chicago-Based Cohort.
Ndebele S, Turner T, Liao C, Aschebrook-Kilfoy B, Randorf N, Ahsan H
Int J Environ Res Public Health. 2024; 21(2).
PMID: 38397711
PMC: 10887769.
DOI: 10.3390/ijerph21020222.
Assessment of a Digital Symptom Checker Tool's Accuracy in Suggesting Reproductive Health Conditions: Clinical Vignettes Study.
Peven K, Wickham A, Wilks O, Kaplan Y, Marhol A, Ahmed S
JMIR Mhealth Uhealth. 2023; 11:e46718.
PMID: 38051574
PMC: 10731551.
DOI: 10.2196/46718.